Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 9;7(19):658-664.
doi: 10.46234/ccdcw2025.108.

A Multi-Regional Epidemiological Evaluation on Post-vaccination Serological Testing in Prevention of Vertical Transmission of Hepatitis B Virus - 10 Counties, 5 Provinces, China, 2019-2024

Affiliations

A Multi-Regional Epidemiological Evaluation on Post-vaccination Serological Testing in Prevention of Vertical Transmission of Hepatitis B Virus - 10 Counties, 5 Provinces, China, 2019-2024

Lin Tang et al. China CDC Wkly. .

Abstract

What is already known about this topic?: Post-vaccination serologic testing (PVST) of infants born to hepatitis B virus (HBV) infected mothers is important for evaluating effectiveness of strategies for preventing mother-to-child transmission (MTCT) of HBV.

What is added by this report?: PVST was conducted in 43.7% of 7,425 infants born to HBV-infected mothers and showed that 0.8% of infants had breakthrough infections, indicating a very low level of prevention failure; anti-HBs positivity was 97.0% showing vaccine-induced protection; and 2.2% of HBV-exposed infants needed revaccination. Prevention failure was 12.7-fold higher among infants born to HBeAg-positive mothers.

What are the implications for public health practice?: MTCT prevention strategy is highly effective. PVST evaluates MTCT prevention strategy and identifies infants needing revaccination; its use should be increased. Findings support WHO's HBV elimination strategy.

Keywords: HBsAg; Hepatitis B Virus; Post-vaccination serological testing; mother-to-child transmission.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest declared by any authors.

References

    1. Kyuregyan KK, Kichatova VS, Isaeva OV, Potemkin IA, Malinnikova EY, Lopatukhina MA, et al Coverage with timely administered vaccination against hepatitis B virus and its influence on the prevalence of HBV infection in the regions of different endemicity. Vaccines. 2021;9(2):82. doi: 10.3390/vaccines9020082. - DOI - PMC - PubMed
    1. World Health Organization. Hepatitis B. 2024. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. [2025-3-20].

    1. Miao N, Wang FZ, Zheng H, Yin ZD, Zhang GM Hepatitis B vaccine coverage and factors influencing coverage among children 1-14 years of age in China in 2020. Chin J Vaccines Immun. 2022;28(6):679–83. doi: 10.19914/j.CJVI.2022125. - DOI
    1. Zheng H, Wang Y, Wang FZ, Shen LP, Zhang GM, Liu JH, et al New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg Health West Pac. 2024;51:101193. doi: 10.1016/j.lanwpc.2024.101193. - DOI - PMC - PubMed
    1. Lu QB, Cui F Preventing mother-to-child transmission of HBV. Lancet Infect Dis. 2022;22(8):1096–7. doi: 10.1016/S1473-3099(22)00216-X. - DOI - PubMed

LinkOut - more resources